- Signal Genetics Inc SGNL shares tumbled 20.8 percent to $11.48. Signal Genetics shares have jumped 2,859.18 percent over the past 52 weeks, while the S&P 500 index has climbed 22.18 percent in the same period.
- X T L Biopharmaceuticals Ltd (ADR) XTLB shares fell 14.1 percent to $2.58. XTL Biopharmaceuticals disclosed that it has expanded its clinical advisory board to support Phase II trial of HCDR1 in Sjogren's syndrome.
- Dipexium Pharmaceuticals Inc DPRX shares declined 14 percent to $1.16. Dipexium Pharmashares have dropped 80.23 percent over the past 52 weeks, while the S&P 500 index has gained 22.18 percent in the same period.
- Hain Celestial Group Inc HAIN shares dropped 12.4 percent to $33.75 after the company announced a SEC subpoena seeking documents related to delayed filing.
- Biocept Inc BIOC shares fell 11.4 percent to $2.10.
- Knoll Inc KNL shares declined 9.8 percent to $24.41. Knoll on Friday posted Q4 earnings of $21.4 million on revenue of $292.9 million.
- Inovalon Holdings Inc INOV shares fell 8.8 percent to $11.18. Inovalon is expected to release Q4 earnings on February 22, 2017. Bank of America downgraded Inovalon to Underperform.
- Gannett Co Inc GCI shares dropped 6.5 percent to $8.36. Argus Research downgraded Gannett from Buy to Hold.
- Axovant Sciences Ltd AXON slipped 6 percent to $11.92. Axovant Sciences announced plans to expand patient recruitment for its Phase 2 study.
- Covanta Holding Corp CVA dropped 3 percent to $15.50. Stifel Nicolaus downgraded Covanta from Buy to Hold.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in